Masonic Cancer Center, University of Minnesota: all 285 studies

Page 2 of 3. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.

• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic CancerTerminatedNCT00963872Phase 1/2Results posted
• Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00903630Phase 1/2Results posted
• Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast CancerCompletedNCT00895414Not applicableResults posted
• Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT00882206Phase 2Results posted
• Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AMLTerminatedNCT00871689Phase 2Results posted
• Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative DisordersTerminatedNCT00869323Phase 2Results posted
• Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaTerminatedNCT00818649Phase 2Results posted
• Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast CaTerminatedNCT00784524Phase 2Results posted
• Allogeneic Transplantation For Severe OsteopetrosisCompletedNCT00775931Phase 2/3Results posted
• Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00726739Phase 2Results posted
• Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of MetabolismTerminatedNCT00668564Phase 2Results posted
• Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal CancerTerminatedNCT00652899Phase 2Results posted
• Reduced Intensity AlloTransplant For OsteopetrosisTerminatedNCT00638820Phase 2Results posted
• Stem Cell Transplant in Treating Patients With Acute Myeloid LeukemiaTerminatedNCT00630565Phase 2/3Results posted
• Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi AnemiaCompletedNCT00630253Phase 1/2Results posted
• Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT00625729Phase 1/2Results posted
• Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell HistiocytosisTerminatedNCT00618540Phase 2Results posted
• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantTerminatedNCT00617929Phase 2Results posted
• Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial CancerCompletedNCT00617188Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaCompletedNCT00612716Phase 2Results posted
• CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial CancerCompletedNCT00610740Phase 2Results posted
• Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell TransplantationTerminatedNCT00609739Phase 1/2Results posted
• Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantTerminatedNCT00602446Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis BullosaTerminatedNCT00478244Not applicableResults posted
• Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAACompletedNCT00455312Phase 2/3Results posted
• Autologous Peripheral Blood Stem Cell Transplant for Germ Cell TumorsCompletedNCT00432094Phase 2Results posted
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung CancerCompletedNCT00400803Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other DiseaseTerminatedNCT00392782Phase 2Results posted
• HSCT for High Risk Inherited Inborn ErrorsCompletedNCT00383448Phase 2Results posted
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedNCT00381888Phase 2Results posted
• Phase II of Naltrexone in Hormone-Refractory Metastatic Breast CancerTerminatedNCT00379197Phase 2Results posted
• Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast CancerTerminatedNCT00376805Phase 2Results posted
• Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic ChemotherapyCompletedNCT00365547Phase 2Results posted
• Hematopoietic Stem Cell Transplantation in the Treatment of Infant LeukemiaCompletedNCT00357565Phase 2Results posted
• Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.TerminatedNCT00354172Phase 2Results posted
• TBI Dose De-escalation for Fanconi AnemiaCompletedNCT00352976Phase 2/3Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTerminatedNCT00352118Phase 2Results posted
• Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNCT00345865Phase 2Results posted
• Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerTerminatedNCT00331422Phase 2Results posted
• Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical CancersCompletedNCT00319748Phase 2Results posted
• Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesCompletedNCT00309842Phase 2Results posted
• Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood TransplantCompletedNCT00305682Phase 2Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell TransplantCompletedNCT00303667Phase 1/2Results posted
• Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerTerminatedNCT00295880Phase 1/2Results posted
• Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineCompletedNCT00293293Not applicableResults posted
• Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in SituTerminatedNCT00290654Phase 2Results posted
• Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung CancerTerminatedNCT00281827Phase 2Results posted
• Study of Immune Response Modifier in the Treatment of Hematologic MalignanciesTerminatedNCT00276159Phase 2Results posted
• Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00274846Phase 2Results posted
• Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
• Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi AnemiaCompletedNCT00258427Phase 2Results posted
• Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial CancerCompletedNCT00258362Phase 2Results posted
• Autologous Transplant for Multiple MyelomaCompletedNCT00177047Phase 2/3Results posted
• Stem Cell Transplant for Hematological MalignancyTerminatedNCT00176930Not applicableResults posted
• Stem Cell Transplantation for HurlerCompletedNCT00176917Phase 2Results posted
• Stem Cell Transplant for Inborn Errors of MetabolismCompletedNCT00176904Phase 2/3Results posted
• Stem Cell Transplant w/Laronidase for HurlerCompletedNCT00176891Phase 2Results posted
• Stem Cell Transplant for Bone Marrow Failure SyndromesCompletedNCT00176878Phase 2/3Results posted
• Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
• Stem Cell Transplant for HemoglobinopathyCompletedNCT00176852Phase 2/3Results posted
• Stem Cell Transplantation for Hematological MalignanciesTerminatedNCT00176839Phase 2/3Results posted
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
• Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)CompletedNCT00167219Phase 1/2Results posted
• Stem Cell Transplantation for Fanconi AnemiaTerminatedNCT00167206Phase 1/2Results posted
• Post Transplant Donor Lymphocyte InfusionTerminatedNCT00167180Phase 2Results posted
• LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal CancerActive, not recruitingNCT07153016Not applicable
• Remote Trial - Tobacco Product Standard (VLNC)TerminatedNCT06442384Not applicable
• Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerActive, not recruitingNCT06342986Phase 1
• Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking MeasuresActive, not recruitingNCT06295757Not applicable
• Effect of Kava on Anxiety and Stress in Cancer SurvivorsWithdrawnNCT06213298Early Phase 1
• MT2022-01: MSCs for ALDSuspendedNCT06030648Phase 1
• EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy ToxicityCompletedNCT05809557Not applicable
• Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)WithdrawnNCT05705700Phase 2
• Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV ViremiaWithdrawnNCT05700630Phase 1
• Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer SurvivorsActive, not recruitingNCT05665543Not applicable
• Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.Active, not recruitingNCT05634512
• NF-1, Nutraceutical InterventionActive, not recruitingNCT05363267Phase 1
• Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated CorticosteroidsTerminatedNCT05123040Phase 1/2
• Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALLWithdrawnNCT05114837Phase 1/2
• Charcoal in Lung Cancer Patients Undergoing TEMLAWithdrawnNCT04928950Phase 2
• Vegetable Intake Effect on Heterocyclic Amine MetabolismTerminatedNCT04882423Not applicable
• Study of Periodontitis and Blood Stream Infection in AML Patients Receiving ChemotherapyTerminatedNCT04858594
• Ph I/II Study of E7777 Prior to CAR-T for R/R LBCLSuspendedNCT04855253Phase 1/2
• Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette ChoicesCompletedNCT04740008Early Phase 1
• A Phase II, Open Label Study of ONC201 in Adults With EGFR-low GlioblastomaWithdrawnNCT04629209Phase 2
• Diagnosis and Treatment of Periodontal Disease in Patients With AMLWithdrawnNCT04530695Not applicable
• Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-CelActive, not recruitingNCT04514029Early Phase 1
• Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With HypoxiaCompletedNCT04363346Phase 1
• Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)CompletedNCT04225572Not applicable
• Tobacco Constituents and BiomarkersCompletedNCT04090606
• Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen ExposureActive, not recruitingNCT03998735Phase 1
• Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast CancerCompletedNCT03981705
• BAriaTric Surgery After Breast Cancer Treatment (BATS)WithdrawnNCT03946423Not applicable
• Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple MyelomaNo longer availableNCT03850704
• Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive ChemotherapyCompletedNCT03728699
• Trial of Indole-3-Carbinol and SilibininCompletedNCT03687073Phase 1
• COMET2 Project 1 Filter Ventilation StudyCompletedNCT03637972Phase 3
• Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal TrainingCompletedNCT03609203

← Masonic Cancer Center, University of Minnesota overview and focus areas